SCHEMBL27170474

SCHEMBL27170474

CCCC(OCC)c1ccc2c3c(cccc13)C(=O)OC2=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 6/20 0.44
▸ KMT2A Q03164 6/20 0.36
▸ MEN1 O00255 5/20 0.36
▸ POLB P06746 3/20 0.36
▸ KDM4E B2RXH2 4/20 0.33
▸ MAPT P10636 4/20 0.33
▸ PABPC1 P11940 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ KEAP1 Q14145 2/20 0.33
▸ NFE2L2 Q16236 2/20 0.33
▸ USP2 O75604 2/20 0.33
▸ ATM Q13315 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TLR9 Q9NR96 2/20 0.32
▸ MAPK1 P28482 2/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27170472 0.84 KMT2A (0.50) KMT2AMEN1POLBKDM4EMAPT
Trifluoromethanesulfonic Acid SCHEMBL29093191 0.77 POLB (0.36) KMT2AMEN1POLBKDM4EMAPT
SCHEMBL27170470 0.76 KMT2A (0.39) KMT2AMEN1POLBKDM4EMAPT
SCHEMBL29092889 0.75 KDM4E (0.31) TYMSKDM4ELMNA
SCHEMBL30533227 0.75 KDM4E (0.31) TYMSKDM4ELMNA
SCHEMBL30533225 0.75 — —
SCHEMBL29092918 0.75 — —
SCHEMBL27170471 0.74 ALDH1A1 (0.39) KMT2AMEN1POLBKDM4EMAPT
SCHEMBL29093200 0.74 GPR84 (0.38) KMT2AKDM4EMAPTALDH1A1LMNA
SCHEMBL15702319 0.74 TYMS (0.56) TYMSKMT2AMEN1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12625427-B2 Naphthalimide sulfonate derivative, and photoacid generator and photoresist composition each comprising same SAMYANG CORPORATION (KR) 2026-05-12 — — US disclosed
US-20240085786-A1 NOVEL NAPHTHALIMIDE SULFONATE DERIVATIVE, AND PHOTOACID GENERATOR AND PHOTORESIST COMPOSITION EACH COMPRISING SAME SAMYANG CORPORATION (KR) 2024-03-14 — — US disclosed
WO-2022145986-A1 NOVEL NAPHTHALIMIDE SULFONATE DERIVATIVE, AND PHOTOACID GENERATOR AND PHOTORESIST COMPOSITION EACH COMPRISING SAME 주식회사 삼양사 2022-07-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240085786-A1 NOVEL NAPHTHALIMIDE SULFONATE DERIVATIVE, AND PHOTOACID GENERATOR AND PHOTORESIST COMPOSITION EACH COMPRISING SAME ALAD, PSAT1, PIN1 TYMS 1194/4885KMT2A 2346/4885MEN1 2324/4885
US-12625427-B2 Naphthalimide sulfonate derivative, and photoacid generator and photoresist composition each comprising same HCCS, ALAD, CYP2S1 TYMS 2576/4885KMT2A 3548/4885MEN1 3323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback